Preliminary experience with a new sclerosing foam in the treatment of varicose veins
- PMID: 11231246
Preliminary experience with a new sclerosing foam in the treatment of varicose veins
Abstract
Background: Recently a new method of using a foam sclerosing agent for the treatment of leg veins has been described. We present a pilot study of a new technique for producing the sclerosing foam (Tessari's method) (SFT) and its use in sclerotherapy of major and minor varicosities.
Objective: A preliminary multicenter experience of sclerotherapy performed by means of this new kind of sclerosing foam made of purified sodium tetradecylsulfate is described. The authors evaluated the safety and efficacy of different doses and concentrations of the drug as well as different methods of preparing the foam in addition, the results of this technique were evaluated.
Methods: Over a 6-week period the three authors performed sclerotherapy or duplex-guided sclerotherapy using SFT, treating 77 patients. The SFT was formed using a three-way stopcock and two syringes, mixing air with liquid sodium tetradecylsulfate to create a foam. Each author used different concentrations (0.1-3%) and doses (2-8 ml) of SFT according to the size and number of the veins. Alternate methods of preparing the foam were examined as well. Seventy percent of the sclerotherapy sessions were performed on either the long or short saphenous veins, recurrent varices, or collaterals. Thirty percent of the treatments were for reticular varices and telangiectases.
Results: At 1-month follow-up, the vast majority of treated larger veins were either obliterated or showed a normal state of cephalad blood flow. Results for minor varicosities were good, but with related complications of hyperpigmentation and small areas of cutaneous necrosis. Two patients experienced transient scotomas and one patient developed segmental phlebitis of a collateral vein. The best foam was obtained by mixing one part liquid sodium tetradecylsulfate and four to five parts air, but the duration of the foam product was also related to several other factors.
Conclusion: This preliminary pilot study demonstrates that the technique of producing sclerosing foam according to Tessari's method (three-way stopcock device) is very promising, especially for larger veins. No serious complications were reported, and further standardization of the method may improve the results and feasibility of this technique. Further studies are needed to validate this new technique.
Similar articles
-
Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.Dermatol Surg. 2002 Jan;28(1):11-5. doi: 10.1046/j.1524-4725.2002.01182.x. Dermatol Surg. 2002. PMID: 11991262
-
Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.Dermatol Surg. 2004 May;30(5):718-22; discussion 722. doi: 10.1111/j.1524-4725.2004.30202.x. Dermatol Surg. 2004. PMID: 15099313
-
Review of published information on foam sclerotherapy.Dermatol Surg. 2010 Jun;36 Suppl 2:983-92. doi: 10.1111/j.1524-4725.2009.01406.x. Dermatol Surg. 2010. PMID: 20590705 Review.
-
[Echo-guided compression sclerotherapy using foam: an improvement in the treatment of varicose veins].Ned Tijdschr Geneeskd. 2006 Aug 12;150(32):1758-63. Ned Tijdschr Geneeskd. 2006. PMID: 16948234 Review. Dutch.
-
European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.Dermatol Surg. 2004 May;30(5):709-17; discussion 717. doi: 10.1111/j.1524-4725.2004.30209.x. Dermatol Surg. 2004. PMID: 15099312 Review.
Cited by
-
A mechanism for improved talc pleurodesis via foam delivery.Drug Deliv. 2021 Dec;28(1):733-740. doi: 10.1080/10717544.2021.1895910. Drug Deliv. 2021. PMID: 33827326 Free PMC article.
-
New treatments for varicose veins.BMJ. 2002 Mar 23;324(7339):689-90. doi: 10.1136/bmj.324.7339.689. BMJ. 2002. PMID: 11909771 Free PMC article. No abstract available.
-
Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations.Cardiovasc Intervent Radiol. 2018 Jun;41(6):856-866. doi: 10.1007/s00270-017-1855-2. Epub 2018 Feb 7. Cardiovasc Intervent Radiol. 2018. PMID: 29417264 Free PMC article.
-
Left spermatic vein retrograde sclerosis: comparison between sclerosant agent injection through a diagnostic catheter versus through an occluding balloon catheter.Radiol Med. 2015 May;120(5):483-8. doi: 10.1007/s11547-014-0478-9. Epub 2014 Dec 2. Radiol Med. 2015. PMID: 25450868 Clinical Trial.
-
A Novel Foam Contrast Agent Suitable for Fluoroscopic Interventional Procedure: Comparative Study of Physical Properties and Experimental Intervention in Animal Model.Biomed Res Int. 2015;2015:974537. doi: 10.1155/2015/974537. Epub 2015 Aug 20. Biomed Res Int. 2015. PMID: 26366422 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical